Using Commercial Insights in the Out-Licensing of Biopharma Assets

Positioning a product for successful out-licensing or acquisition is challenging, but the likelihood of achieving an attractive exit can be significantly de-risked by proactive, strategic planning. To maximize an exit before NDA submission, it is critical that sponsors understand the out-licensing environment and how strengths and weaknesses can be leveraged to create a win-win situation.

Register for this webinar to hear an outline of the strategic work that should begin during the earlier phases of development, before licensing or sales discussions begin, and will provide guidance on best practices from a strategic development perspective.

Robb Lawrence, SVP of Commercial Strategy Solutions, Camargo